Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLCPRNewsWire • 09/02/21
Abbott's (ABT) Heart Failure Device Study Outcome Favorable (Revised)Zacks Investment Research • 09/02/21
Late-Breaking Data Shows Abbott's Amplatzer™ Amulet™ Occluder Offers Superior Left Atrial Appendage Closure Compared to Watchman‡ Device for People With Atrial Fibrillation at Risk of StrokePRNewsWire • 08/30/21
GUIDE-HF Study Data Show Abbott's CardioMEMS™ Device Can Improve Care for More Patients with Heart FailurePRNewsWire • 08/27/21
Abbott's Amplatzer™ Amulet™ Device Approved by FDA to Treat People With Atrial Fibrillation at Risk of StrokePRNewsWire • 08/16/21
My Dividend Growth Portfolio July Update: $500K Across 32 Holdings, 3 Buys, And 2 SellsSeeking Alpha • 08/05/21
Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the HeartPRNewsWire • 08/03/21
U.S. says Abbott units to pay $160 million to resolve alleged false Medicare claimsReuters • 08/02/21